BioSpace News Archive

MabVax Therapeutics Holdings, Inc. announced that David Hansen, MabVax’s President and Chief Executive Officer, will present live at VirtualInvestorConferences.com on May 3, 2018.

The Company plans to begin commercial sales of the pump in select international markets beginning in the second half of 2018.

Camargo Pharmaceutical Services, LLC, announced the appointment of Daniel S. Duffy as new Chief Executive Officer.

An entertaining and engaging fictionalized story based on hard to swallow facts, “Bless This Mess: A Picture Story of Healthcare in America” by Stephen K. Klasko, MD, MBA, chronicles a futuristic look back at America’s past and current healthcare system as reviewed by the Intergalactic Health Council.

Biologica Technologies, LLC (the “Company” or “Biologica”) announced today that they will be exhibiting their first pieces of clinical data for ProteiOS growth factor at this week’s American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in New Orleans, LA. Biologica will be located in Booth #846.

[30-April-2018] JERUSALEM, April 30, 2018 /PRNewswire/ -- RenalSense(R) has entered into an agreement with Fresenius Medical Care (Bad Homburg) for distribution of its Clarity RMS(R) critical care urine monitoring system in Europe, the Middle East, and Africa (EMEA). Fresenius Medical Care will market the company’s products in 85 EMEA countries through its acute care div

Trial to evaluate the safety and effectiveness of the TearCare® System in patients with dry eye disease.

According to the Mesothelioma Victims Center, “If you are a Navy Veteran or a shipyard worker with mesothelioma and your exposure to asbestos happened at the navy base/shipyard at Norfolk, Virginia please call us anytime at 800-714-0303.

In advance of May 2018’s Lyme Disease Awareness Month, Irene McGee, (http://www.nap4lyme.org), has announced what could be the best internet challenge to date… a nap challenge.

Nektar Therapeutics (NASDAQ:NKTR) announced today that it will host an analyst and investor event with clinical investigators on Saturday, June 2, 2018 at 6:45 p.m. CDT in Chicago, IL during the 2018 American Society of Clinical Oncology (ASCO) Meeting.